文献速递肾小球疾病

原发性膜性肾病中M型跨膜磷脂酶A2受体T细胞表位的定位

Mapping the T cell epitopes of the M-type transmembrane phospholipase A2 receptor in primary membranous nephropathy.
PubMed 文献 · Kidney Int · 2022-12-20

研究合成覆盖PLA2R十个结构域的123条线性多肽,评估其与风险及保护性HLA分子的结合能力,并检测抗PLA2R阳性膜性肾病患者CD4+ T细胞增殖和细胞因子分泌。鉴定出17条与DRB1*1501和DRB1*0301高亲和力结合的多肽,其中10条可诱导患者CD4+ T细胞显著增殖,并促进IL-6、TNF-α、IL-10、IL-9和IL-17等促炎因子产生。

要点

  • 覆盖PLA2R十个结构域的123条线性多肽中,17条与DRB1*1501和DRB1*0301高亲和力结合。
  • 10条多肽可诱导抗PLA2R阳性膜性肾病患者CD4+ T细胞显著增殖。
  • 这些多肽激活患者外周血单个核细胞后产生较高水平的IL-6、TNF-α、IL-10、IL-9和IL-17。

核心结论

  • 在PLA2R的CysR、FnII、CTLD3、CTLD5和CTLD7结构域中定位并鉴定出10条多肽作为膜性肾病潜在T细胞表位。
  • 这些发现是开发多肽特异性免疫疗法的第一步。

研究设计与样本

  • 研究合成123条线性多肽,每条含15-22个氨基酸、相邻多肽重叠8-12个氨基酸,覆盖PLA2R十个结构域。
  • 用流式细胞术评估多肽与风险HLA分子(DRB1*1501、DRB1*0301)及保护性HLA分子(DRB1*0901、DRB1*0701)的结合能力。
  • 分析抗PLA2R阳性膜性肾病患者CD4+ T细胞在多肽刺激后的增殖,并用 cytometric bead array 检测活化外周血单个核细胞产生的细胞因子。

主要发现

  • 鉴定出17条与DRB1*1501和DRB1*0301均高容量结合的PLA2R多肽,部分多肽与杂合DRB1*1501/0901和DRB1*0301/0701的结合下降。
  • 17条多肽中的10条(CysR1、CysR10、CysR12、FnII-3、CTLD3-9、CTLD3-10、CTLD3-11、CTLD5-2-1、CTLD7-1和CTLD7-2)诱导膜性肾病患者CD4+ T细胞增殖显著高于健康个体。
  • 这些多肽激活后,膜性肾病患者外周血单个核细胞产生更高水平的促炎细胞因子,以IL-6、TNF-α、IL-10、IL-9和IL-17为主。

关键数值与推荐

  • 10条候选T细胞表位多肽:CysR1、CysR10、CysR12、FnII-3、CTLD3-9、CTLD3-10、CTLD3-11、CTLD5-2-1、CTLD7-1和CTLD7-2。
  • 风险HLA分子为DRB1*1501和DRB1*0301,保护性HLA分子为DRB1*0901和DRB1*0701。

临床怎么用

  • 原文结论指出这些发现是开发多肽特异性免疫疗法的第一步,未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The M-type phospholipase A2 receptor (PLA2R) is the major autoantigen of primary membranous nephropathy (MN). Despite many studies on B-cell epitopes recognized by antibodies, little is known about T-cell epitopes. Herein, we synthesized 123 linear peptides, each consisting of 15-22 amino acids with 8-12 amino acid overlaps, across ten domains of PLA2R. Their binding capacity to risk (DRB1∗1501, DRB1∗0301) and protective (DRB1∗0901, DRB1∗0701) HLA molecules was then assessed by flow cytometry. Proliferation of CD4+ T cells from patients with anti-PLA2R positive MN was analyzed after peptide stimulation. Cytokines produced by activated peripheral blood mononuclear cells were measured by cytometric bead arrays. We identified 17 PLA2R peptides that bound to both DRB1∗1501 and DRB1∗0301 molecules with high capacity. Some of these peptides showed decreased binding to heterozygous DRB1∗1501/0901 and DRB1∗0301/0701. Ten of the 17 peptides (CysR1, CysR10, CysR12, FnII-3, CTLD3-9, CTLD3-10, CTLD3-11, CTLD5-2-1, CTLD7-1 and CTLD7-2) induced significant proliferation of CD4+ T cells from patients with MN than cells from healthy individuals. Upon activation by these peptides, peripheral blood mononuclear cells from patients with MN produced higher levels of pro-inflammatory cytokines, predominantly IL-6, TNF-α, IL-10, IL-9 and IL-17. Thus, we mapped and identified ten peptides in the CysR, FnII, CTLD3, CTLD5, and CTLD7 domains of PLA2R as potential T-cell epitopes of MN. These findings are a first step towards developing peptide-specific immunotherapies.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Zhang XD, Lin CX, Cui Z, et al. Mapping the T cell epitopes of the M-type transmembrane phospholipase A2 receptor in primary membranous nephropathy. Kidney Int. 2022. PMID: 36549363. doi:10.1016/j.kint.2022.11.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。